reference/26866641

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/26866641

Outgoing Links

Predicate	Object
contentType	Comparative Study\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, N.I.H., Extramural
endingPage	50
issn	1469-8978 0033-2917
issueIdentifier	1
pageRange	41-50
publicationName	Psychological Medicine
startingPage	41
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_cd23225bb8277d80089ba14432de98d3
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_c2fa28f103f3dbd97c10ccc65b9b7b59 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_255f47bbdec0a3af027f46cc12bc4ccd
bibliographicCitation	Nierenberg AA, Husain MM, Trivedi MH, Fava M, Warden D, Wisniewski SR, Miyahara S, Rush AJ. Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report. Psychol. Med. 2009 May 22;40(1):41–50. doi: 10.1017/s0033291709006011.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c84dd35b5631bb986ee5af07f4a25e7b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e747e7d1e7d3143bc99fd01432dfd857 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9b488dc58cec710aaf249e22c61c089c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9792260995baa60b4b157f8dd2ffc653 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_71ad850679b39397b790abc9f66dedb2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_179581f965c61efcdd949134f10b034b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0fb57480c8511113a6016f3acf294579 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e1f9f5f52a21e069b624cc772f9377e4
date	2009-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/19460188 https://pubmed.ncbi.nlm.nih.gov/PMC5886713 https://doi.org/10.1017/s0033291709006011
isPartOf	https://portal.issn.org/resource/ISSN/1469-8978 https://portal.issn.org/resource/ISSN/0033-2917 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/6777
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report
discusses	http://id.nlm.nih.gov/mesh/M0023529 http://id.nlm.nih.gov/mesh/M0028000
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D003865Q000188 http://id.nlm.nih.gov/mesh/D018687Q000627 http://id.nlm.nih.gov/mesh/D015283Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D005500 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D015283Q000009 http://id.nlm.nih.gov/mesh/D012307 http://id.nlm.nih.gov/mesh/D011594 http://id.nlm.nih.gov/mesh/D010555Q000706 http://id.nlm.nih.gov/mesh/D003865Q000523 http://id.nlm.nih.gov/mesh/D003865Q000175 http://id.nlm.nih.gov/mesh/D053208 http://id.nlm.nih.gov/mesh/D055815 http://id.nlm.nih.gov/mesh/D015928 http://id.nlm.nih.gov/mesh/D018687Q000009 http://id.nlm.nih.gov/mesh/D015430 http://id.nlm.nih.gov/mesh/D012008 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D007319Q000523 http://id.nlm.nih.gov/mesh/D000328
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7025 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7428 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7427 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2771 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8177 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9251

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53788845 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129626560

Total number of triples: 63.